Skip to content

Comparative Study Between Posterior Lumbar Interbody Fusion(PLIF) and Intertransverse Process Fusion in Treatment of Spodylolithesis

Comparative Study Between Posterior Lumbar Interbody Fusion(PLF) and Intertransverse Process Fusion in Treatment of Spodylolithesis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03271060
Enrollment
30
Registered
2017-09-01
Start date
2017-09-01
Completion date
2019-09-01
Last updated
2017-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spondylolisthesis

Brief summary

The first technique described for interbody fusion was the anterior lumbar interbody fusion (ALIF).(20) For this technique, the intervertebral disc is accessed through a retroperitoneal or transperitoneal approach. While the posterior approach was first described by Russell Hibbs in 1911, in the 1950's, Cloward (7)popularized the posterior approach for a posterior lumbar interbody fusion (PLIF).

Detailed description

In this study we will try to identify the benefits and outcome of posterior lumbar interbody fusion and inter transverse process bone graft fusion.

Interventions

Lumbar fusion by screws and inter vertebral cage

PROCEDUREInter transverse bone grafting

Inter transverse process bone grafting by bone graft from illiac crest or other sites

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Posterior inter body fusion and inter transverse process bone graft

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* lumbar spondylolisthesis

Exclusion criteria

* infection of lumbar spine

Design outcomes

Primary

MeasureTime frameDescription
Back pain1year postoperativeBack pain severity grading mild, moderate, severe

Contacts

Primary ContactMahmoud Garamoun, Resident
Garamoun.mahmoud@yahoo.com201091123869

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026